Among those, the Notch signaling pathway was found to be upregulated in preneoplastic lesions as well as in invasive tumors of the pancreas in both mice and humans [3–10], and targeting Notch2/Notch3 inhibited patient-derived xenograft tumor growth and decreased frequency of tumor-initiating cells [11]. This evidence concerns the gene NOTCH3 and neoplasm.